Original Query: ALL
Previous Study | Return to List | Next Study

DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00330369
Recruitment Status : Completed
First Posted : May 26, 2006
Last Update Posted : March 18, 2014
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2009
  Study Completion Date : January 2009
  Certification/Extension First Submitted : January 3, 2014